IV-361

• UNSPSC Description:

  IV-361 is an orally active and selective CDK7 inhibitor (Ki≤50 nM). IV-361 has anti-cancer activity (US20190256531A1)[1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/iv-361.html

• Smiles:

  O=C(N(C1)C(C)(C)C2=C1C(NC(C3([Si](C)(C)C)CCC3)=O)=NN2)NC4=CC(F)=CC=C4C

• Molecular Weight:

  457.62

• References & Citations:

  [1]Noriaki Iwase, et al. Substituted dihydropyrrolopyrazole derivative. US20190256531A1.

• Shipping Conditions:

  Room Temperature

• CAS Number:

  2055741-39-2